The Epoch Times
The Epoch Times
AD
The Epoch Times
AMERICA

Ohio Pharmacy Board Reverses Ban on Hydroxychloroquine for COVID-19

Google LogoMark Us Preferred on Google
Ohio Pharmacy Board Reverses Ban on Hydroxychloroquine for COVID-19
Ohio Gov. Mike DeWine speaks to mourners at a memorial service in the Oregon District held to recognize the victims of an early-morning mass shooting in the popular nightspot on Aug. 04, 2019 in Dayton, Ohio. Scott Olson/Getty Images
Tom Ozimek
Tom Ozimek
Reporter
7/30/2020|Updated: 7/30/2020

Ohio Gov. Mike DeWine called on the Ohio Board of Pharmacy to reverse its new ban on hydroxychloroquine for the treatment of COVID-19 infections, and the Board withdrew the proposed rule.

DeWine, a Republican, said in a statement that he believes, as does Dr. Steven Hahn, Commissioner of the Food and Drug Administration (FDA), that the matter of prescribing the drug is an individual health issue best settled between a doctor and a patient.

Google LogoMark Us Preferred on Google
Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Author’s Selected Articles
US Strike Destroys Drug Boat in Eastern Pacific, Killing 2
May 09, 2026
US Strike Destroys Drug Boat in Eastern Pacific, Killing 2
Iran Attacks UAE After US Warships Exchange Fire With Iranian Forces in Hormuz
May 08, 2026
Iran Attacks UAE After US Warships Exchange Fire With Iranian Forces in Hormuz
Trump Warns Iran of Renewed Bombing at ‘Much Higher’ Intensity if Deal Fails
May 06, 2026
Trump Warns Iran of Renewed Bombing at ‘Much Higher’ Intensity if Deal Fails
Trump Paused Hormuz Naval Mission Amid Progress in Iran Talks: Israeli Officials
May 06, 2026
Trump Paused Hormuz Naval Mission Amid Progress in Iran Talks: Israeli Officials
Related Topics
Mike DeWine
hydroxychloroquine
ohio pharmarcy board
AD
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.